Please use this identifier to cite or link to this item:
|Title:||Antimalarial drug development and new targets|
Biomolecular Research Institute
Hebrew University of Jerusalem
La Trobe University
|Keywords:||Immunology and Microbiology|
|Citation:||Parasitology Today. Vol.16, No.10 (2000), 438-444|
|Abstract:||The Molecular Approaches to Malaria (MAM2000) conference, Lorne, Australia, 2-5 February 2000, brought together world-class malaria research scientists. The development of new tools and technologies - transfection, DNA microarrays and proteomic analysis - and the availability of DNA sequences generated by the Malaria Genome Project, along with more classic approaches, have facilitated the identification of novel drug targets, the development of new antimalarials and the generation of a deeper understanding of the molecular mechanism(s) of drug resistance in malaria. It is hoped that combinations of these technologies could lead to strategies that enable the development of effective, efficient and affordable new drugs to overcome drug-resistant malaria, as discussed at MAM2000 and outlined here by Ian Macreadie and colleagues. Copyright (C) 2000 Elsevier Science Ltd.|
|Appears in Collections:||Scopus 1991-2000|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.